AI‑Designed Universal COVID‑19 Vaccine Enters Phase‑1 Trials BPC‑157: The Scientist Who’s Ready to Talk Skeptics A Glimmer of Hope: NKGen Biotech's Trocleucel Shows Remarkable Cognitive Gains in Parkinson's Trial LB Pharma Ignites Wall Street with Dazzling Trading Debut, Shares Soar on Schizophrenia Drug Promise